Press Release
Search Results for: mir-122
Publications
REVIEW – MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Industry News
Regulus Announces Grant of Patents Covering Lead microRNA Therapeutics
Industry News
RG-101 Update: Regulus Expands Development of RG-101 through Clinical Trial Collaboration with GSK
Industry News
Regulus Aims to Advance microRNA Therapeutics Portfolio and Regulus microMarkersSM Division
Publications
Novel Biomarkers for Drug-induced Liver Injury
Industry News
microRNA-122: Positive Preclinical Profile of a GalNAc-conjugated anti-miR Supports Clinical Development for the Treatment of HCV
Industry News
Regulus Provides Update on ‘Road to the Clinic’ Strategy and Reports First Quarter 2013 Financial Results and Recent Highlights
News, Press Release
Antiviral Drug Miravirsen: Final Phase 2a results show dose-dependent, prolonged antiviral activity in Hepatitis C patients
- 1
- 2